art 3 Amendment of Schedule 3A to the principal Order
In the table in Schedule 3A to the principal Order (substances which may be prescribed, administered or directed for administration by extended formulary nurse prescribers and conditions for such prescription or administration)— (a) for the entry for “Erythromycin”, in column 2, after “External Use” insert “or oral”; (b) for the entry “Fusidic acid”, in column 2 for “Opthalmic Use” substitute “External Use”; (c) for the entry “Hycosine butylbromide”, in column 2, after “parenteral” insert “or transdermal”; (d) for the entry “Hycosine hydrobromide”, in column 2, for “Oral, parenteral or transdermal administration in palliative care” substitute “Oral or parenteral administration in palliative care”; (e) for the entry “Metronidazole”, in column 2 for “External use or oral” substitute “External use, oral or rectal”; (f) for the entry “Prednisolone sodium phosphate”, in column 2, after “Aural” insert “or oral”; (g) in column 1 insert, at the appropriate place in the alphabetical order of the entries as they appear in that column, each of the entries set out in column 1 below, and in column 2 insert, against those entries, the corresponding entries in column 2 below—